The Characteristics and Prognosis of Patients with Clonal Cytopenias of Undetermined Significance, Including Cancer and Therapy-Related Clonal Cytopenias
Year: 2022
Type: article
Source: Blood
Authors: Zhuoer Xie, Alexandra Smith, Rami S. Komrokji, Najla Al Ali, Anand Ashwin Patel, Caner Saygin, Amer M. Zeidan, Jan Philipp Bewersdorf, Ashwin Kishtagari, Joshua F. Zeidner, Catherine C. Coombs, Yazan F. Madanat, James M. Foran, Talha Badar, Pinkal Desai, Charlton Tsai, Elizabeth A. Griffiths, Monzr M. Al Malki, Idoroenyi Amanam, Catherine Lai, Joachim Deeg, Lionel Ades, Cecilia Arana Yi, Afaf Osman, Shira Dinner, Yasmin Abaza, Namrata Chandhok, Deborah Soong, Justin Taylor, Andrew M. Brunner, Hetty E. Carraway, Abhay Singh Singh, Susan M. Geyer, Eric Padron, Mrinal M.M. Patnaik, Michael R. Savona, Aref Al-Kali
Institutions: Mayo Clinic, Moffitt Cancer Center, University of Chicago, Yale Cancer Center, Yale University, Memorial Sloan Kettering Cancer Center, Vanderbilt University, Vanderbilt-Ingram Cancer Center, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Mayo Clinic in Florida, NewYork–Presbyterian Hospital, Weill Cornell Medicine, Roswell Park Comprehensive Cancer Center, City Of Hope National Medical Center, University of Pennsylvania, Fred Hutch Cancer Center, Université Paris Cité, Hôpital Saint-Louis, Mayo Clinic Hospital, University of Utah, Huntsman Cancer Institute, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, University of Miami, Sylvester Comprehensive Cancer Center, Massachusetts General Hospital, Cleveland Clinic
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4310160988